Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Forum for Health Economics & Policy

Editor-in-Chief: Goldman, Dana

2 Issues per year


CiteScore 2017: 0.53

SCImago Journal Rank (SJR) 2017: 0.425
Source Normalized Impact per Paper (SNIP) 2017: 0.297

Online
ISSN
1558-9544
See all formats and pricing
More options …

Insurance and Incentives for Medical Innovation

Alan M Garber / Charles I. Jones / Paul Romer
Published Online: 2006-03-29 | DOI: https://doi.org/10.2202/1558-9544.1006

This paper studies the interactions between health insurance and the incentives for innovation. Although we focus on pharmaceutical innovation, our discussion applies to other industries producing novel technologies for sale in markets with subsidized demand. Standard results in the growth and productivity literatures suggest that firms in many industries may possess inadequate incentives to innovate. Standard results in the health literature suggest that health insurance leads to the overutilization of health care. Our study of innovation in the pharmaceutical industry emphasizes the interaction of these incentives. Because of the large subsidies to demand from health insurance, limits on the lifetime of patents and possibly limits on monopoly pricing may be necessary to ensure that pharmaceutical companies do not possess excess incentives for innovation.

Keywords: health insurance; incentives; innovation

About the article

Published Online: 2006-03-29


Citation Information: Forum for Health Economics & Policy, Volume 9, Issue 2, ISSN (Online) 1558-9544, DOI: https://doi.org/10.2202/1558-9544.1006.

Export Citation

©2011 Walter de Gruyter GmbH & Co. KG, Berlin/Boston.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[2]
Kevin D. Frick and Michael E. Chernew
INQUIRY: The Journal of Health Care Organization, Provision, and Financing, 2009, Volume 46, Number 2, Page 229
[4]
ROSELLA LEVAGGI, MICHELE MORETTO, and PAOLO PERTILE
Journal of Public Economic Theory, 2017, Volume 19, Number 1, Page 121
[5]
Adrian Towse, Michele Pistollato, Jorge Mestre-Ferrandiz, Zeba Khan, Satyin Kaura, and Louis Garrison
International Journal of the Economics of Business, 2015, Volume 22, Number 2, Page 263
[6]
Darius Lakdawalla and Neeraj Sood
Journal of Public Economics, 2009, Volume 93, Number 3-4, Page 541
[7]
Volker Grossmann
Journal of Health Economics, 2013, Volume 32, Number 5, Page 881

Comments (0)

Please log in or register to comment.
Log in